A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...
Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers ...
The BLA approval is supported by data from the COBLT study, FDA dockets and public information, and from a RegeneCyte observational database. The Food and Drug Administration (FDA) has approved the ...
Dear Doctors: My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, which would be full of stem cells. We would like to know how ...
The FDA has approved the first ever umbilical cord blood product for use in stem-cell transplants. Hemacord is indicated for use in hematopoietic stem cell transplants in patients with disorders ...
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...
The umbilical cord — the lifeline between mother and baby — was historically discarded as medical waste after birth. Today, an increasing number of parents are choosing to preserve the cord blood for ...
Adding dilanubicel, a cryopreserved, cord blood (CB)-derived, non-human leukocyte antigen-matched expanded progenitor cell ...
Q: My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, which would be full of stem cells. We would like to know how that works and ...